Formulary
Fluticasone with umeclidinium and vilanterol: Indications, Dosing, Side Effects and Interactions
Fluticasone with umeclidinium and vilanterol clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Fluticasone with umeclidinium and vilanterol: Indications, Dosing, Side Effects and Interactions
Fluticasone with umeclidinium and vilanterol clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Maintenance of moderate-to-severe chronic obstructive pulmonary disease**
- **Adult** (By Inhalation Of Powder): 1 inhalation once daily, dose should be taken at the same time each day.
Cautions
For all beta-2-adrenoceptor agonists, selective Arrhythmias; cardiovascular disease; diabetes (risk of hyperglycaemia and ketoacidosis, especially with intravenous use); hypertension; hyperthyroidism; hypokalaemia; susceptibility to QT-interval prolongation Cautions, further information Hypokalaemia Potentially serious hypokalaemia may result from beta 2 agonist therapy. Particular caution is required in severe asthma or COPD, because this effect may be potentiated by concomitant treatment with theophylline and its derivatives, corticosteroids, diuretics, and by hypoxia. M Cautions For fluticasone with umeclidinium and vilanterol Convulsive disorders; pulmonary tuberculosis; thyrotoxicosis
Side effects
For all beta-2-adrenoceptor agonists, selective Common or very common Arrhythmias; dizziness; headache; hyperglycaemia; palpitations; tremor Rare or very rare Bronchospasm paradoxical (sometimes severe) Side-effects For fluticasone with umeclidinium and vilanterol Common or very common Arthralgia; back pain; constipation; cough; increased risk of infection; oropharyngeal pain Uncommon Bone fracture; dry mouth; dysphonia Frequency not known Vision disorders
Pregnancy
For all beta-2-adrenoceptor agonists, selective Inhaled drugs for asthma can be taken as normal during pregnancy.
Hepatic impairment
For fluticasone with umeclidinium and vilanterol Manufacturer advises caution in moderate to severe impairment.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Fluticasone with umeclidinium and vilanterol in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

